Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

Lignende værker

• Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
  af: Docherty, Kieran F, et al.
  Udgivet: (2020)
• Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial
  af: Kosiborod, Mikhail N., et al.
  Udgivet: (2020)
• Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
  af: Jhund, Pardeep S., et al.
  Udgivet: (2021)
• A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)
  af: McMurray, John J.V., et al.
  Udgivet: (2019)
• Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
  af: Jackson, Alice M., et al.
  Udgivet: (2020)